![](/img/cover-not-exists.png)
PD-145 Long-term survival of NSCLC patients with EGFR mutationstreated with EGFR TKIs gefitinib or erlotinib
Janne, P., Sequist, L., Lindeman, N., Bell, D., Huberman, M., Meyerson, M., Haber, D., Lynch, T., Johnson, B.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80478-7
Date:
July, 2005
File:
PDF, 129 KB
english, 2005